NEA Management Company, LLC - Q3 2013 holdings

$2.52 Billion is the total value of NEA Management Company, LLC's 31 reported holdings in Q3 2013. The portfolio turnover from Q2 2013 to Q3 2013 was 100.0% .

 Value Shares↓ Weighting
SMICY ExitSEMICONDUCTOR MFG INTL CORPsponsored adr$0-2,275,177
-100.0%
-0.37%
OMTH ExitOMTHERA PHARMACEUTICA-LS INC$0-5,838,333
-100.0%
-3.47%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2013-10-30
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
GLYCOMIMETICS INC41Q1 20247.6%
AURINIA PHARMACEUTICALS INC40Q2 20245.0%
CHAMPIONS ONCOLOGY INC36Q2 20241.2%
LEXICON PHARMACEUTICALS INC35Q2 20242.0%
ADAPTIMMUNE THERAPEUTICS PLC34Q2 20249.3%
CRISPR THERAPEUTICS AG31Q2 202411.2%
TREVENA INC31Q3 20213.3%
AKARI THERAPEUTICS PLC31Q2 20230.3%
ARDELYX INC29Q3 202111.9%
VERONA PHARMA PLC29Q2 20249.0%

View NEA Management Company, LLC's complete holdings history.

Latest filings
TypeFiled
N-PX2024-08-30
13F-HR2024-08-14
13F-HR2024-05-15
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-11
13F-HR2023-05-15
13F-HR2023-02-10
13F-HR2022-11-14
13F-HR2022-08-15

View NEA Management Company, LLC's complete filings history.

Compare quarters

Export NEA Management Company, LLC's holdings